![](https://www.signifyresearch.net/wp-content/uploads/2023/12/Signify-Temp-Image-BlueBG-564x420.jpg)
Written by
![Alan Stoddart headshot](https://www.signifyresearch.net/wp-content/uploads/2023/12/Alan-New-for-Website-150x150.jpg)
Alan Stoddart
![Imogen Fitt headshot](https://www.signifyresearch.net/wp-content/uploads/2023/12/Signify-Imogen_F-Profile-@2-150x150.png)
Imogen Fitt
Mass General Brigham has developed two new pathology foundation models. The tools are currently only being utilised for research purposes, but could their success highlight pathology as a fruitful arena for generative AI, or does Mass General Brigham's approach suggest the opposite?
The insight is part of Signify Research's Premium Insight – Generative AI subscription service.
To view the full insight on this development hit the Request Access button above for either a complimentary one month trial or to purchase a subscription.
The Signify Research's Premium Insight – Generative AI subscription service provides:
- Approximately 100 actionable and up to the moment Premium Insights per year.
- A subscription to Signify Premium Insights – Generative AI provides compelling thought leadership on the most pertinent developments in healthcare technology.
- This service utilises Signify Research’s expansive market data to properly appraise and interpret breaking news stories.
- Major market moves and industry-changing announcements are evaluated as they unfold, and the considered opinions of Signify Research’s expert analysts are shared to provide insight into current developments.
- Key vendors, technologies and conferences are followed, with updates carefully scrutinised to ensure that the most important details are revealed and properly assessed.
Read the full insight with a Signify Premium Insights - Digital Health subscription